Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of Lactobacillus Reuteri in Healthy Children Ages 2 to 5 Years in Peru
NCT02124122Phase 1Completed
- Sponsor
- Tulane University
- Start
- Mar 2015
- Primary completion
- Nov 2015
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of lactobacillus reuteri in diarrhea (2 arms), sponsored by Tulane University. Primary endpoints: Number of Participants With Positive Blood Culture for L Reuteri at 36 days and Mean Daily Temperature at Day 36. Started Mar 2015; status: completed.
02
Drugs
lactobacillus reuteri
03
Conditions
diarrhea
Beyond the preview
Go deeper on NCT02124122.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02124122.